Gene therapy: FDA grants priority review to risdiplam for spinal muscular atrophy (SMA)

https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-fda-grants-priority-review-to-risdiplam-for-the-treatment-of-spinal-muscular-atrophy-300964301.html